Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
- PMID: 28419259
- PMCID: PMC5850006
- DOI: 10.1093/cid/cix318
Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis
Abstract
Coccidioidal meningitis (CM) has high morbidity, and adjunctive measures to improve outcomes are needed. Using an established multicenter retrospective cohort study of CM (N = 221), we found that patients receiving adjunctive corticosteroids had a significant reduction in secondary cerebrovascular events (P = .0049). Those with CM-associated cerebrovascular events (8%) may benefit from short-term corticosteroids.
Keywords: coccidioidomycosis; corticosteroids; meningitis; stroke; vasculitis.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
References
-
- Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis 2016; 63:e112–46. - PubMed
-
- Thompson GR., 3rd Pulmonary coccidioidomycosis. Semin Respir Crit Care Med 2011; 32:754–63. - PubMed
-
- Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42:103–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
